Evaluation of the PennPET Explorer Scanner
Evaluation of Long-Axial Field-of-View Positron Emission Tomography (PET) Scanner
This study is testing a new type of PET scanner that can take images of larger areas of the body to see if it helps doctors diagnose diseases better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 99 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pennsylvania Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Trial ID | NCT04617912 on ClinicalTrials.gov |
What this trial studies
This study evaluates the PennPET Explorer, a long-axial field-of-view PET scanner designed to image larger sections of the body compared to traditional PET scanners. Participants will receive a radioactive imaging drug, which may be FDA approved or investigational, to facilitate imaging. The study aims to gather data on the scanner's performance and potential clinical applications, particularly in diagnosing various diseases. The research will involve adult participants who can provide informed consent and will assess the scanner's ability to enhance clinical performance and research applications.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who can provide informed consent.
Not a fit: Patients with serious medical or psychological conditions that may compromise their safety or ability to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic capabilities for a range of diseases through enhanced imaging technology.
How similar studies have performed: Other studies have shown success with advanced imaging technologies, but the long-axial field-of-view approach is relatively novel and under evaluation.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult participants, at least 18 years of age * Participants or study partner must be informed of the investigational nature of this study and provide written informed consent in accordance with institutional and federal guidelines prior to study-specific procedures. Subjects who are unable to provide consent must have a legally authorized representative or designated "study partner" who can provide consent on their behalf. Exclusion Criteria: * Inability to tolerate imaging procedure in the opinion of an investigator. * Serious or unstable medical or psychological conditions or lack of mobility that, in the opinion of the investigator would compromise the subject's safety or successful participation in the study
Where this trial is running
Philadelphia, Pennsylvania
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Study coordinator: Erin K Schubert
- Email: erinschu@pennmedicine.upenn.edu
- Phone: 215-573-6569
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.